KD Logo

Investing in BioAtla Inc (BCAB): What You Must Know

BioAtla Inc’s recent filing unveils that its Director MCBRINN SYLVIA acquired Company’s shares for reported $9320.0 on Dec 26 ’23. In the deal valued at $2.33 per share,4,000 shares were bought. As a result of this transaction, MCBRINN SYLVIA now holds 15,125 shares worth roughly $34182.5.

Then, SHORT JAY M PHD bought 50,000 shares, generating $106,910 in total proceeds. Upon buying the shares at $2.14, the Chief Executive Officer now owns 1,439,283 shares.

Before that, STEINMAN LAWRENCE bought 20,000 shares. BioAtla Inc shares valued at $41,048 were divested by the Director at a price of $2.05 per share. As a result of the transaction, STEINMAN LAWRENCE now holds 38,459 shares, worth roughly $86917.34.

JMP Securities initiated its BioAtla Inc [BCAB] rating to a Mkt outperform in a research note published on September 15, 2022; the price target was $17. A number of analysts have revised their coverage, including Credit Suisse’s analysts, who decreased its forecast for the stock in early May from “an Outperform” to “a Neutral”. H.C. Wainwright began covering BCAB with “Buy” recommendation on March 21, 2022.

Price Performance Review of BCAB

On Tuesday, BioAtla Inc [NASDAQ:BCAB] saw its stock fall -12.60% to $2.26. Over the last five days, the stock has gained 0.67%. BioAtla Inc shares have fallen nearly -8.33% since the year began. Nevertheless, the stocks have fallen -33.09% over the past one year. While a 52-week high of $4.07 was reached on 04/04/24, a 52-week low of $1.24 was recorded on 02/01/24. SMA at 50 days reached $2.77, while 200 days put it at $2.30. A total of 0.66 million shares were traded, compared to the trading of 0.48 million shares in the previous session.

Levels Of Support And Resistance For BCAB Stock

The 24-hour chart illustrates a support level at 2.13, which if violated will result in even more drops to 2.00. On the upside, there is a resistance level at 2.47. A further resistance level may holdings at 2.68. The Relative Strength Index (RSI) on the 14-day chart is 39.92, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.07, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.46%. Stochastics %K at 27.28% indicates the stock is a holding.

The most recent change occurred on June 28, 2021 when ROTH Capital began covering the stock and recommended ‘”a Buy”‘ rating along with a $75 price target.

Most Popular

[the_ad id="945"]